1-[(3R)-1-[9-[(1R,2S,3R,4S)-4-(2,5-dioxoimidazolidin-1-yl)-2,3-dihydroxycyclopentyl]-6-(2,2-diphenylethylamino)purin-2-yl]pyrrolidin-3-yl]-3-pyridin-3-ylurea;2,2,2-trifluoroacetic acid

C39H40F3N11O7 — CID 23655015

IUPAC1-[(3R)-1-[9-[(1R,2S,3R,4S)-4-(2,5-dioxoimidazolidin-1-yl)-2,3-dihydroxycyclopentyl]-6-(2,2-diphenylethylamino)purin-2-yl]pyrrolidin-3-yl]-3-pyridin-3-ylurea;2,2,2-trifluoroacetic acid
SMILESO=C(Nc1cccnc1)N[C@@H]1CCN(c2nc(NCC(c3ccccc3)c3ccccc3)c3ncn([C@@H]4C[C@H](N5C(=O)CNC5=O)[C@@H](O)[C@H]4O)c3n2)C1.O=C(O)C(F)(F)F
InChIInChI=1S/C37H39N11O5.C2HF3O2/c49-29-19-40-37(53)48(29)28-16-27(31(50)32(28)51)47-21-41-30-33(39-18-26(22-8-3-1-4-9-22)23-10-5-2-6-11-23)44-35(45-34(30)47)46-15-13-25(20-46)43-36(52)42-24-12-7-14-38-17-24;3-2(4,5)1(6)7/h1-12,14,17,21,25-28,31-32,50-51H,13,15-16,18-20H2,(H,40,53)(H,39,44,45)(H2,42,43,52);(H,6,7)/t25-,27-,28+,31+,32-;/m1./s1
InChIKeyFBBCMRNGTHETDE-OVJAGGLTSA-N
MW831.81 g/mol
LogP3.09
Rot. Bonds10

About 1-[(3R)-1-[9-[(1R,2S,3R,4S)-4-(2,5-dioxoimidazolidin-1-yl)-2,3-dihydroxycyclopentyl]-6-(2,2-diphenylethylamino)purin-2-yl]pyrrolidin-3-yl]-3-pyridin-3-ylurea;2,2,2-trifluoroacetic acid

1-[(3R)-1-[9-[(1R,2S,3R,4S)-4-(2,5-dioxoimidazolidin-1-yl)-2,3-dihydroxycyclopentyl]-6-(2,2-diphenylethylamino)purin-2-yl]pyrrolidin-3-yl]-3-pyridin-3-ylurea;2,2,2-trifluoroacetic acid (PubChem CID 23655015) has the molecular formula C39H40F3N11O7 and a molecular weight of 831.81 g/mol. Its IUPAC name is 1-[(3R)-1-[9-[(1R,2S,3R,4S)-4-(2,5-dioxoimidazolidin-1-yl)-2,3-dihydroxycyclopentyl]-6-(2,2-diphenylethylamino)purin-2-yl]pyrrolidin-3-yl]-3-pyridin-3-ylurea;2,2,2-trifluoroacetic acid.

Molecular Properties

Compound Name1-[(3R)-1-[9-[(1R,2S,3R,4S)-4-(2,5-dioxoimidazolidin-1-yl)-2,3-dihydroxycyclopentyl]-6-(2,2-diphenylethylamino)purin-2-yl]pyrrolidin-3-yl]-3-pyridin-3-ylurea;2,2,2-trifluoroacetic acid
PubChem CID23655015
Molecular FormulaC39H40F3N11O7
Molecular Weight831.81 g/mol
Exact Mass831.31
IUPAC Name1-[(3R)-1-[9-[(1R,2S,3R,4S)-4-(2,5-dioxoimidazolidin-1-yl)-2,3-dihydroxycyclopentyl]-6-(2,2-diphenylethylamino)purin-2-yl]pyrrolidin-3-yl]-3-pyridin-3-ylurea;2,2,2-trifluoroacetic acid
SMILESO=C(Nc1cccnc1)N[C@@H]1CCN(c2nc(NCC(c3ccccc3)c3ccccc3)c3ncn([C@@H]4C[C@H](N5C(=O)CNC5=O)[C@@H](O)[C@H]4O)c3n2)C1.O=C(O)C(F)(F)F
InChIInChI=1S/C37H39N11O5.C2HF3O2/c49-29-19-40-37(53)48(29)28-16-27(31(50)32(28)51)47-21-41-30-33(39-18-26(22-8-3-1-4-9-22)23-10-5-2-6-11-23)44-35(45-34(30)47)46-15-13-25(20-46)43-36(52)42-24-12-7-14-38-17-24;3-2(4,5)1(6)7/h1-12,14,17,21,25-28,31-32,50-51H,13,15-16,18-20H2,(H,40,53)(H,39,44,45)(H2,42,43,52);(H,6,7)/t25-,27-,28+,31+,32-;/m1./s1
InChIKeyFBBCMRNGTHETDE-OVJAGGLTSA-N
XLogP3.09
TPSA240.06 Ų
H-Bond Donors7
H-Bond Acceptors13
Rotatable Bonds10
Heavy Atoms60
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500831.81
LogP ≤ 53.09
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze 1-[(3R)-1-[9-[(1R,2S,3R,4S)-4-(2,5-dioxoimidazolidin-1-yl)-2,3-dihydroxycyclopentyl]-6-(2,2-diphenylethylamino)purin-2-yl]pyrrolidin-3-yl]-3-pyridin-3-ylurea;2,2,2-trifluoroacetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[(3R)-1-[9-[(1R,2S,3R,4S)-4-(2,5-dioxoimidazolidin-1-yl)-2,3-dihydroxycyclopentyl]-6-(2,2-diphenylethylamino)purin-2-yl]pyrrolidin-3-yl]-3-pyridin-3-ylurea;2,2,2-trifluoroacetic acid?
The IUPAC name of 1-[(3R)-1-[9-[(1R,2S,3R,4S)-4-(2,5-dioxoimidazolidin-1-yl)-2,3-dihydroxycyclopentyl]-6-(2,2-diphenylethylamino)purin-2-yl]pyrrolidin-3-yl]-3-pyridin-3-ylurea;2,2,2-trifluoroacetic acid (CID 23655015) is 1-[(3R)-1-[9-[(1R,2S,3R,4S)-4-(2,5-dioxoimidazolidin-1-yl)-2,3-dihydroxycyclopentyl]-6-(2,2-diphenylethylamino)purin-2-yl]pyrrolidin-3-yl]-3-pyridin-3-ylurea;2,2,2-trifluoroacetic acid.
What is the SMILES notation for 1-[(3R)-1-[9-[(1R,2S,3R,4S)-4-(2,5-dioxoimidazolidin-1-yl)-2,3-dihydroxycyclopentyl]-6-(2,2-diphenylethylamino)purin-2-yl]pyrrolidin-3-yl]-3-pyridin-3-ylurea;2,2,2-trifluoroacetic acid?
The canonical SMILES for 1-[(3R)-1-[9-[(1R,2S,3R,4S)-4-(2,5-dioxoimidazolidin-1-yl)-2,3-dihydroxycyclopentyl]-6-(2,2-diphenylethylamino)purin-2-yl]pyrrolidin-3-yl]-3-pyridin-3-ylurea;2,2,2-trifluoroacetic acid is O=C(Nc1cccnc1)N[C@@H]1CCN(c2nc(NCC(c3ccccc3)c3ccccc3)c3ncn([C@@H]4C[C@H](N5C(=O)CNC5=O)[C@@H](O)[C@H]4O)c3n2)C1.O=C(O)C(F)(F)F.
What is the InChIKey of 1-[(3R)-1-[9-[(1R,2S,3R,4S)-4-(2,5-dioxoimidazolidin-1-yl)-2,3-dihydroxycyclopentyl]-6-(2,2-diphenylethylamino)purin-2-yl]pyrrolidin-3-yl]-3-pyridin-3-ylurea;2,2,2-trifluoroacetic acid?
The InChIKey is FBBCMRNGTHETDE-OVJAGGLTSA-N. The full InChI is InChI=1S/C37H39N11O5.C2HF3O2/c49-29-19-40-37(53)48(29)28-16-27(31(50)32(28)51)47-21-41-30-33(39-18-26(22-8-3-1-4-9-22)23-10-5-2-6-11-23)44-35(45-34(30)47)46-15-13-25(20-46)43-36(52)42-24-12-7-14-38-17-24;3-2(4,5)1(6)7/h1-12,14,17,21,25-28,31-32,50-51H,13,15-16,18-20H2,(H,40,53)(H,39,44,45)(H2,42,43,52);(H,6,7)/t25-,27-,28+,31+,32-;/m1./s1.
What are the key properties of 1-[(3R)-1-[9-[(1R,2S,3R,4S)-4-(2,5-dioxoimidazolidin-1-yl)-2,3-dihydroxycyclopentyl]-6-(2,2-diphenylethylamino)purin-2-yl]pyrrolidin-3-yl]-3-pyridin-3-ylurea;2,2,2-trifluoroacetic acid?
1-[(3R)-1-[9-[(1R,2S,3R,4S)-4-(2,5-dioxoimidazolidin-1-yl)-2,3-dihydroxycyclopentyl]-6-(2,2-diphenylethylamino)purin-2-yl]pyrrolidin-3-yl]-3-pyridin-3-ylurea;2,2,2-trifluoroacetic acid has a molecular weight of 831.81 g/mol, XLogP of 3.09, 10 rotatable bonds, 7 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[(3R)-1-[9-[(1R,2S,3R,4S)-4-(2,5-dioxoimidazolidin-1-yl)-2,3-dihydroxycyclopentyl]-6-(2,2-diphenylethylamino)purin-2-yl]pyrrolidin-3-yl]-3-pyridin-3-ylurea;2,2,2-trifluoroacetic acid is sourced from PubChem (CID 23655015), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).